STAT3 and hepatocellular carcinoma: The results of SEN LU et al. showed that GYY4137(a donor of H2S) suppressed IL-6-induced STAT3 activation through effectively decreasing p-STAT3 levels by reducing JAK2 phosphorylation (an activator of STAT3) in HCC cells.